• Mary-Ellen Taplin, MD

    Professor of Medicine
    Dana-Farber Cancer Institute
    Harvard Medical School


    Dr. Mary-Ellen Taplin is Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, Director of Clinical Research for the Dana-Farber Lank Center of Genitourinary Oncology and Chairperson of the DFCI Executive Committee for Clinical Research. Dr. Taplin is an expert genitourinary clinician and a mentor to many junior investigators. She serves as lead investigator on many projects including the Prostate Cancer Clinical Trials Consortium, Dana-Farber SPORE grant, Stand Up 2 Cancer and several Prostate Cancer Foundation Challenge Grants.

    Dr. Taplin is dedicated to clinical and translational investigations that focus on novel approaches to treat localized high-risk prostate cancer and secondary hormone therapy for metastatic castration-resistant prostate cancer. Her research has described molecular and physiologic alterations in the androgen receptor pathway in the context of prostate cancer resistance.
     
This website uses cookies to ensure you get the best experience on our website. For more information on the cookies we use, please reference our Privacy Policy.